News

Inviragen is a developer of vaccines to protect against infectious diseases worldwide. The MOU calls for the formation of a management committee co-chaired by Casey and Dan Stinchcomb,

In the initial study with SinoFresh Homeopathic Antiseptic Nasal Spray, SinoFresh HealthCare expects to assess symptom relief for chronic sinusitis sufferers. SinoFresh is planning to conduct the trials

Earlier, Takeda collaborated with its wholly-owned subsidiaries Takeda San Francisco, Millennium Pharmaceuticals, Takeda Bio Development Center and Chemistry, Manufacturing and Controls (CMC) Center to commercialize new drug candidate

The study will evaluate ANA598, the company’s direct-acting antiviral, in both treatment-naive patients and patients who have failed a prior course of HCV therapy with interferon and ribavirin.

The randomized, controlled study will compare the use of Tryton stent in the side branch and a standard drug eluting stent in the main vessel versus angioplasty in

Following the termination of the pact, Anapharm Europe’s majority shareholder Maria Cruz Caturla has acquired PharmaNet’s minority ownership interest, and now he is the sole owner of the

Jiangchuan macrolide facility holds both macrolide API production license from China’s State Food and Drug Administration (SFDA) and related business licenses from the Industry and Commerce Bureau and

Pfenex is now set to start the process development activities with immediate action so as to offer materials to SAIC for ongoing pre-clinical studies. The current contract is

As per the terms of the agreement, the FDA will offer non-proprietary toxicology data for a variety of toxicological endpoints: including, carcinogenicity, developmental toxicity, genetic toxicity, and reproductive